ProPhase Labs to Present at the Investor Summit Virtual on March 11
ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and consumer products company, has announced its participation in the upcoming Q1 Investor Summit Virtual on March 11, 2025. CEO Ted Karkus will deliver a presentation at 1:30 P.M. ET.
The Investor Summit is an exclusive event focused on small and microcap stocks, specifically targeting undervalued MicroCap companies with catalysts. The event provides investors an opportunity to interact with management teams, learn from industry experts, and network with peers.
Interested investors can register for free at the Investor Summit Group website to access the presentation, which will be available at the provided webcast link.
ProPhase Labs (NASDAQ: PRPH), una compagnia biotech di nuova generazione, genomica e di prodotti per consumatori, ha annunciato la sua partecipazione al prossimo Q1 Investor Summit Virtual che si terrà l'11 marzo 2025. Il CEO Ted Karkus presenterà un intervento alle 13:30 ET.
Il Summit degli Investitori è un evento esclusivo incentrato su azioni small e microcap, specificamente rivolto a compagnie MicroCap sottovalutate con catalizzatori. L'evento offre agli investitori l'opportunità di interagire con i team di gestione, apprendere da esperti del settore e fare networking con i colleghi.
Gli investitori interessati possono registrarsi gratuitamente sul sito web del Investor Summit Group per accedere alla presentazione, che sarà disponibile al link del webcast fornito.
ProPhase Labs (NASDAQ: PRPH), una empresa de biotecnología de nueva generación, genómica y de productos de consumo, ha anunciado su participación en el próximo Q1 Investor Summit Virtual el 11 de marzo de 2025. El CEO Ted Karkus realizará una presentación a la 1:30 P.M. ET.
El Investor Summit es un evento exclusivo centrado en acciones small y microcap, dirigido específicamente a empresas MicroCap subvaluadas con catalizadores. El evento ofrece a los inversores la oportunidad de interactuar con los equipos de gestión, aprender de expertos de la industria y hacer networking con sus pares.
Los inversores interesados pueden registrarse gratuitamente en el sitio web del Investor Summit Group para acceder a la presentación, que estará disponible en el enlace del webcast proporcionado.
ProPhase Labs (NASDAQ: PRPH), 차세대 생명공학, 유전체학 및 소비자 제품 회사가 2025년 3월 11일에 열리는 Q1 Investor Summit Virtual에 참여한다고 발표했습니다. CEO Ted Karkus는 오후 1시 30분 ET에 발표를 진행할 예정입니다.
Investor Summit은 소형 및 마이크로캡 주식에 초점을 맞춘 독점 이벤트로, 촉매가 있는 저평가된 MicroCap 기업을 특별히 겨냥하고 있습니다. 이 이벤트는 투자자들에게 경영진과 상호작용하고, 업계 전문가로부터 배우며, 동료들과 네트워킹할 수 있는 기회를 제공합니다.
관심 있는 투자자들은 Investor Summit Group 웹사이트에서 무료로 등록하여 제공된 웹캐스트 링크를 통해 발표에 접근할 수 있습니다.
ProPhase Labs (NASDAQ: PRPH), une entreprise de biotechnologie de nouvelle génération, de génomique et de produits de consommation, a annoncé sa participation au prochain Q1 Investor Summit Virtual qui se tiendra le 11 mars 2025. Le PDG Ted Karkus fera une présentation à 13h30 ET.
Le Investor Summit est un événement exclusif axé sur les actions small et microcap, ciblant spécifiquement les entreprises MicroCap sous-évaluées avec des catalyseurs. L'événement offre aux investisseurs l'opportunité d'interagir avec les équipes de direction, d'apprendre auprès d'experts de l'industrie et de réseauter avec leurs pairs.
Les investisseurs intéressés peuvent s'inscrire gratuitement sur le site Web du Investor Summit Group pour accéder à la présentation, qui sera disponible via le lien de webdiffusion fourni.
ProPhase Labs (NASDAQ: PRPH), ein Unternehmen der nächsten Generation in den Bereichen Biotechnologie, Genomik und Verbrauchermarkt, hat seine Teilnahme am bevorstehenden Q1 Investor Summit Virtual am 11. März 2025 angekündigt. CEO Ted Karkus wird um 13:30 Uhr ET eine Präsentation halten.
Der Investor Summit ist eine exklusive Veranstaltung, die sich auf Small- und Microcap-Aktien konzentriert und speziell auf unterbewertete MicroCap-Unternehmen mit Katalysatoren abzielt. Die Veranstaltung bietet Investoren die Möglichkeit, mit dem Management-Team zu interagieren, von Branchenexperten zu lernen und sich mit Gleichgesinnten zu vernetzen.
Interessierte Investoren können sich kostenlos auf der Website der Investor Summit Group registrieren, um auf die Präsentation zuzugreifen, die über den bereitgestellten Webcast-Link verfügbar sein wird.
- None.
- None.
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced that Ted Karkus, CEO, will be presenting at this year’s Investor Summit Virtual on March 11th.
Event: Q1 Investor Summit
Presentation Time: 1:30 P.M. ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52134
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued and have a catalyst.
Registration for Investors
To request free registration, please go to https://investorsummitgroup.com and click the “Registration” button.
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
212-812-7680
Jboidman@renmarkfinancial.com
FAQ
When is ProPhase Labs (PRPH) presenting at the Q1 Investor Summit Virtual 2025?
How can investors attend ProPhase Labs' (PRPH) Investor Summit presentation?
What is the focus of the Q1 Investor Summit where PRPH is presenting?
Who will represent ProPhase Labs (PRPH) at the Q1 2025 Investor Summit?
